P Fabris
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
- Hematology 15
- Chronic Myeloid Leukemia Treatments 6
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 4
- Multiple Myeloma Research and Treatments 4
-
- Acute Lymphoblastic Leukemia research 9
- Co-authors
- P Coser (6 shared papers)Giuseppe Rossi (7 shared papers)Manfred Mitterer (3 shared papers)Alessandro Rambaldi (6 shared papers)Tiziano Barbui (2 shared papers)R Bassan (2 shared papers)Emanuele Angelucci (1 shared paper)Caterina Micò (1 shared paper)
- Journals
- British Journal of Haematology (3 papers)Haematologica (2 papers)Blood (1 paper)Acta Haematologica (1 paper)Advances in experimental medicine and biology (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
P Fabris
22 papers receiving 326 citations
Peers
Comparison fields: 5 of 39
- Hematology 262
- Public Health, Environmental and Occupational Health 173
- Genetics 60
- Oncology 78
- Pathology and Forensic Medicine 49
Countries citing papers authored by P Fabris
This map shows the geographic impact of P Fabris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Fabris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Fabris more than expected).
Fields of papers citing papers by P Fabris
This network shows the impact of papers produced by P Fabris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Fabris. The network helps show where P Fabris may publish in the future.
Co-authors
The 25 scholars most cited alongside P Fabris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 96 | |
| 2 | Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups. | 2004 | 63 |
| 3 | 1999 | 26 | |
| 4 | 2001 | 22 | |
| 5 | 2001 | 22 | |
| 6 | 2000 | 17 | |
| 7 | Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high-dose chemotherapy and rh-G-CSF. | 1996 | 17 |
| 8 | 1987 | 14 | |
| 9 | Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study. | 1999 | 13 |
| 10 | 1987 | 9 | |
| 11 | 1994 | 8 | |
| 12 | The role of anthracyclines in adult acute lymphoblastic leukaemia. | 1996 | 7 |
| 13 | 1994 | 6 | |
| 14 | Short-course imatinib (IM) added to chemotherapy improves early but not long-term outcome in adult Ph/BCR-ABL+ acute lymphoblastic leukemia (ALL) : 5-year follow-up results of study NILG-09 | 2008 | 4 |
| 15 | 2000 | 4 | |
| 16 | 1957 | 3 | |
| 17 | [Multiple myeloma terminating in acute myeloid leukaemia in a patient with a beta-thalassemia trait. A case report (author's transl)]. | 1977 | 3 |
| 18 | 1999 | 2 | |
| 19 | Role of anthracycline dose intensity in adult Philadelphia chromosome/BCR-ABL positive and negative B-lineage acute lymphoblastic leukemia | 1999 | 2 |
| 20 | Retrospective survival analysis of elderly patients with acute myeloid leukemia (AML) treated with aggressive or non aggressive therapy | 2000 | 2 |
About P Fabris
P Fabris is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 343 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Multiple Myeloma Research and Treatments (4 papers), Lymphoma Diagnosis and Treatment (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Hematology (262 citations), Public Health, Environmental and Occupational Health (173 citations), Genetics (60 citations), Oncology (78 citations) and Pathology and Forensic Medicine (49 citations). P Fabris has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include P Coser, Giuseppe Rossi, Manfred Mitterer, Alessandro Rambaldi, Tiziano Barbui, R Bassan, Emanuele Angelucci, Caterina Micò, Vittoria Guerini and Aldo Salvi. Their work appears in journals such as British Journal of Haematology, Haematologica, Blood, Acta Haematologica and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.